At this point, it is unclear if these medications will lead to sustained weight loss that delivers positive health benefits," Rayburg said
Pricing Disclaimer: All pricing and availability information reflects company disclosures at the time of publication (January 2026) and is subject to change without notice
Choosing the appropriate GLP-1 receptor agonist depends on your individual health profile, treatment goals, and lifestyle preferences
In particular: NICE Technology Appraisal TA875 provides a positive recommendation for semaglutide (Wegovy) for chronic weight management in adults meeting specific criteria (BMI 35 kg/m with at least one weight-related comorbidity, or BMI 3034.9 kg/m in certain circumstances), when used within a specialist weight management service
Front Public Health 10:960965
Nutrition 16 (10), 9961005